• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素抵抗指数预测2型糖尿病患者非酒精性脂肪性肝病的潜力。

The potential of insulin resistance indices to predict non-alcoholic fatty liver disease in patients with type 2 diabetes.

作者信息

Tian Jie, Cao Yutian, Zhang Wenhui, Wang Aiyao, Yang Xinyi, Dong Yinfeng, Zhou Xiqiao

机构信息

School of Nursing, Nanjing University of Chinese Medicine, Nanjing, China.

Department of Endocrinology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

BMC Endocr Disord. 2024 Dec 4;24(1):261. doi: 10.1186/s12902-024-01794-z.

DOI:10.1186/s12902-024-01794-z
PMID:39633354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11616383/
Abstract

BACKGROUND

The triglyceride-glucose (TyG) index and related parameters, as well as the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), have been developed as insulin resistance markers to identify individuals at risk for non-alcoholic fatty liver disease (NAFLD). However, its use for predicting NAFLD in patients with type 2 diabetes mellitus (T2DM) remains unclear. In this study, we aimed to observe the performance of insulin resistance indices in diagnosing NAFLD combined with T2DM and to compare their diagnostic values in clinical practice.

PATIENTS AND METHODS

Overall, 268 patients with T2DM from the Endocrinology Department of Jiangsu Provincial Hospital of Traditional Chinese Medicine were enrolled in this study and divided into two groups: an NAFLD group (T2DM with NAFLD) and a T2DM group (T2DM without NAFLD). General information and blood indicators of the participants were collected, and insulin resistance indices were calculated based on these data. Receiver operating characteristic (ROC) analysis was conducted to calculate the area under the curve (AUC) for insulin resistance-related indices, aiming to assess their ability to discriminate between T2DM patients with and without NAFLD.

RESULTS

ROC analysis revealed that among the five insulin resistance-related indices, four parameters (TyG, TyG-body mass index [BMI], TyG-waist circumference [WC], and TyG- (waist-hip ratio [WHR]) exhibited high predictive performance for identifying NAFLD, except for HOMA-IR (AUCs:0.710,0.738,0.737 and 0.730, respectivly). TyG-BMI demonstrated superior predictive value, especially in males. For males, the AUC for TyG-BMI was 0.764 (95% confidence interval [CI] 0.691-0.827). The sensitivity and specificity for male NAFLD were 90.32% and 47.89%, respectively. Moreover, in the Generalized linear regression models, there were positive associations of TyG, TyG-BMI, TyG-WC, TyG-WHR, and HOMA-IR with controlled attenuation parameter (CAP), with β values of 21.30, 0.745, 0.247, and 2.549 (all P < 0.001), respectively.

CONCLUSION

TyG-BMI is a promising predictor of NAFLD combined with T2DM, particularly in lean male patients.

摘要

背景

甘油三酯-葡萄糖(TyG)指数及相关参数,以及胰岛素抵抗的稳态模型评估(HOMA-IR),已被开发作为胰岛素抵抗标志物,用于识别非酒精性脂肪性肝病(NAFLD)风险个体。然而,其在2型糖尿病(T2DM)患者中预测NAFLD的应用仍不明确。在本研究中,我们旨在观察胰岛素抵抗指数在诊断合并T2DM的NAFLD中的表现,并比较它们在临床实践中的诊断价值。

患者与方法

本研究共纳入江苏省中医院内分泌科的268例T2DM患者,分为两组:NAFLD组(合并NAFLD的T2DM)和T2DM组(不合并NAFLD的T2DM)。收集参与者的一般信息和血液指标,并基于这些数据计算胰岛素抵抗指数。进行受试者工作特征(ROC)分析,以计算胰岛素抵抗相关指数的曲线下面积(AUC),旨在评估它们区分合并和不合并NAFLD的T2DM患者的能力。

结果

ROC分析显示,在五个胰岛素抵抗相关指数中,四个参数(TyG、TyG-体重指数[BMI]、TyG-腰围[WC]和TyG-腰臀比[WHR])在识别NAFLD方面表现出较高的预测性能,HOMA-IR除外(AUC分别为0.710、0.738、0.737和0.730)。TyG-BMI显示出更高的预测价值,尤其是在男性中。对于男性,TyG-BMI的AUC为0.764(95%置信区间[CI] 0.691-0.827)。男性NAFLD的敏感性和特异性分别为90.32%和47.89%。此外,在广义线性回归模型中,TyG、TyG-BMI、TyG-WC、TyG-WHR和HOMA-IR与受控衰减参数(CAP)呈正相关,β值分别为21.30、0.745、0.247和2.549(均P<0.001)。

结论

TyG-BMI是合并T2DM的NAFLD的一个有前景的预测指标,尤其是在瘦男性患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/60ee11447496/12902_2024_1794_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/9ef869f76700/12902_2024_1794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/28db2a5352f6/12902_2024_1794_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/431f687590a9/12902_2024_1794_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/60ee11447496/12902_2024_1794_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/9ef869f76700/12902_2024_1794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/28db2a5352f6/12902_2024_1794_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/431f687590a9/12902_2024_1794_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/11616383/60ee11447496/12902_2024_1794_Fig4_HTML.jpg

相似文献

1
The potential of insulin resistance indices to predict non-alcoholic fatty liver disease in patients with type 2 diabetes.胰岛素抵抗指数预测2型糖尿病患者非酒精性脂肪性肝病的潜力。
BMC Endocr Disord. 2024 Dec 4;24(1):261. doi: 10.1186/s12902-024-01794-z.
2
Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus.甘油三酯血糖-体质指数在预测2型糖尿病患者非酒精性脂肪性肝病中的价值。
Front Endocrinol (Lausanne). 2025 Jan 20;15:1425024. doi: 10.3389/fendo.2024.1425024. eCollection 2024.
3
The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.肥胖和脂质相关指标对预测非酒精性脂肪性肝病的存在的有用性。
Lipids Health Dis. 2021 Oct 10;20(1):134. doi: 10.1186/s12944-021-01561-2.
4
Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease.胰岛素抵抗指数对代谢功能障碍相关脂肪性肝病的诊断效能
Metab Syndr Relat Disord. 2024 Jun;22(5):402-409. doi: 10.1089/met.2023.0276. Epub 2024 Apr 4.
5
Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.甘油三酯葡萄糖指数及相关参数(甘油三酯葡萄糖-体重指数和甘油三酯葡萄糖-腰围)可识别超重/肥胖个体的非酒精性脂肪肝和肝纤维化。
Metab Syndr Relat Disord. 2021 Apr;19(3):167-173. doi: 10.1089/met.2020.0109. Epub 2020 Dec 1.
6
Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents.评估胰岛素抵抗和脂质相关指标预测肥胖青少年非酒精性脂肪性肝病(NAFLD)的能力。
Lipids Health Dis. 2024 Jul 2;23(1):208. doi: 10.1186/s12944-024-02144-7.
7
Mediating role of triglyceride-glucose index and its derivatives in the relationship between central obesity and Hashimoto thyroiditis in type 2 diabetes.甘油三酯-葡萄糖指数及其衍生物在2型糖尿病患者中心性肥胖与桥本甲状腺炎关系中的中介作用
Lipids Health Dis. 2024 Dec 19;23(1):411. doi: 10.1186/s12944-024-02402-8.
8
Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.甘油三酯-血糖-腰围身高比:一种新型且有效的标志物,可用于识别 2 型糖尿病患者的肝脂肪变性。
Endocrine. 2021 Dec;74(3):538-545. doi: 10.1007/s12020-021-02815-w. Epub 2021 Aug 5.
9
Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.三酰甘油葡萄糖指数联合体重指数对 2 型糖尿病患者非酒精性脂肪肝的诊断价值。
BMC Endocr Disord. 2022 Apr 15;22(1):101. doi: 10.1186/s12902-022-00993-w.
10
Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.甘油三酯-葡萄糖-体重指数与非酒精性脂肪性肝病患者非酒精性肝炎和纤维化分期的关系。
Ann Med. 2024 Dec;56(1):2409342. doi: 10.1080/07853890.2024.2409342. Epub 2024 Sep 30.

引用本文的文献

1
Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.甘油三酯葡萄糖-体质指数(TyG-BMI)与代谢功能障碍相关脂肪性肝病的关联:一项系统评价和荟萃分析
PLoS One. 2025 Aug 4;20(8):e0324483. doi: 10.1371/journal.pone.0324483. eCollection 2025.

本文引用的文献

1
[Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)].《代谢功能障碍相关(非酒精性)脂肪性肝病防治指南(2024年版)》
Zhonghua Gan Zang Bing Za Zhi. 2024 May 20;32(5):418-434. doi: 10.3760/cma.j.cn501113-20240327-00163.
2
Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.与非糖尿病人群中非酒精性脂肪性肝病相关的胰岛素抵抗标志物。
Sci Rep. 2023 Nov 22;13(1):20470. doi: 10.1038/s41598-023-47269-4.
3
Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
甘油三酯-血糖-腰围:筛查非肥胖成年人非酒精性脂肪肝的最佳指标。
BMC Gastroenterol. 2023 Nov 2;23(1):376. doi: 10.1186/s12876-023-03007-8.
4
Gender Differences in Insulin Resistance: New Knowledge and Perspectives.胰岛素抵抗中的性别差异:新知识与新视角。
Curr Issues Mol Biol. 2023 Sep 27;45(10):7845-7861. doi: 10.3390/cimb45100496.
5
The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018.甘油三酯-葡萄糖指数是糖尿病或糖尿病前期心血管疾病患者心血管和全因死亡的预测指标:来自 NHANES 2001-2018 的证据。
Cardiovasc Diabetol. 2023 Oct 17;22(1):279. doi: 10.1186/s12933-023-02030-z.
6
Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease.比较十二种代谢相关脂肪性肝病无创评分对代谢相关脂肪性肝病的诊断性能。
Lipids Health Dis. 2023 Sep 6;22(1):145. doi: 10.1186/s12944-023-01902-3.
7
Can we use old NAFLD data under the new MASLD definition?在新的代谢相关脂肪性肝病(MASLD)定义下,我们能否使用旧的非酒精性脂肪性肝病(NAFLD)数据?
J Hepatol. 2024 Feb;80(2):e54-e56. doi: 10.1016/j.jhep.2023.07.021. Epub 2023 Aug 2.
8
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.全球 2 型糖尿病中非酒精性脂肪性肝病的患病率:一项更新的系统评价和荟萃分析。
Gut. 2023 Nov;72(11):2138-2148. doi: 10.1136/gutjnl-2023-330110. Epub 2023 Jul 25.
9
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
10
Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants.甘油三酯-葡萄糖相关标志物与代谢相关脂肪性肝病风险的相关性:一项在中国健康参与者中的横断面研究。
BMJ Open. 2023 May 2;13(5):e070189. doi: 10.1136/bmjopen-2022-070189.